Maze Therapeutics, Inc. MAZE

26.05 (0.16) (0.61%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
411.09 352.38 341.92 383.94

+8 more quarters

Receivables
— 20.00 — —
Total current assets
420.42 379.78 349.72 391.30
Property, Plant, Equpment (Net)
4.39 4.68 5.04 5.54
Long-Term Investments
83.82 10.56 18.11 —
Long-term assets (Other)
4.55 5.41 4.14 4.30
Total non-current assets
111.20 39.93 47.41 30.76
Total Assets
531.63 419.71 397.13 422.06
Accounts Payable
2.21 4.01 1.79 2.92
Accrued Expenses
15.87 12.39 15.97 14.43
Total current liabilities
22.96 21.24 22.56 22.11
Long Term Debt (Total)
38.96 38.83 — —
Non-current Liabilities (Other)
— 0.39 1.09 1.09
Total non-current liabilities
55.54 56.77 19.61 20.51
Total liabilities
78.50 78.01 42.16 42.62
Additional Paid In Capital
1,011.99 855.54 844.35 834.30
Common Stock (Net)
0.06 0.05 0.05 0.05
Retained Earnings
(558.48) (513.75) (489.55) (454.98)
Common Equity (Total)
453.12 341.70 354.97 379.44
Shareholders Equity (Total)
453.12 341.70 354.97 379.44
Shareholders Equity and Liabilities (Total)
531.63 419.71 397.13 422.06
Shares (Common)
55.51 49.74 49.34 48.08
Shareholders Equity (Tangible)
453.12 341.70 354.97 379.44
Net Debt
(372.13) (313.55) (341.92) (383.93)
Total Debt
38.96 38.83 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates